water for mixing peptides FAQ

Discard it immediately. Do not attempt to use it. Cloudiness indicates either bacterial contamination introduced during reconstitution or protein aggregation caused by incorrect pH, temperature shock, or expired BAC water. Visible particles are often rubber stopper fragments cored by a dull or oversized needle, or precipitated peptide aggregates. Neither condition is reversible. Using contaminated or aggregated peptide solutions introduces infection risk and guarantees zero bioavailability. The denatured protein won't bind to target receptors.

Temperature excursion above 8°C for more than 4 hours causes measurable potency loss in most research peptides. If the vial was at room temperature (20–25°C) for 8–12 hours, expect 15–30% reduction in bioavailability depending on the peptide's thermal stability profile. For heat-sensitive compounds like Cerebrolysin or P21, overnight ambient storage may reduce potency by 40–60%. Document the temperature excursion and adjust dosing upward if continuing the study, or discard and reconstitute a fresh vial if precision is critical.

Bacteriostatic water's 0.9% benzyl alcohol preservative maintains antimicrobial efficacy for 28 days post-opening. Beyond that window, bacterial contamination risk rises exponentially even under refrigeration. Some peptides retain structural stability past 28 days, but without antimicrobial protection the solution is unsafe for injection. If your study extends beyond four weeks, reconstitute smaller batches more frequently rather than mixing the entire supply upfront. For long-duration research protocols involving compounds like Survodutide or Mazdutide, plan reconstitution timing around the 28-day sterility ceiling.

Stop using it immediately. Cloudiness indicates peptide aggregation or bacterial contamination, both of which render the solution unsafe and ineffective. Aggregation occurs when peptide chains clump together due to improper reconstitution technique (shaking instead of swirling), temperature stress, or prolonged storage beyond stability limits. Bacterial contamination appears as cloudiness, floating particles, or color change and signals complete loss of sterility. Never inject a cloudy peptide solution. For researchers using BPC 157 or TB 500, a properly reconstituted peptide should be crystal clear with no visible particulates. Any deviation from this means the vial is compromised.

Do not use it for research-grade peptide reconstitution. Absence of expiration date and certificate of analysis indicates the product was not manufactured under pharmaceutical quality control standards. You cannot verify benzyl alcohol concentration, pH, endotoxin levels, or sterility. Any of which, if incorrect, will compromise your peptide and your research outcomes. Source BAC water only from suppliers who provide lot-specific COA documentation and manufacturing facility identification. At Real Peptides, every vial of bacteriostatic water includes COA documentation and is manufactured at an FDA-registered 503B facility following USP <797> sterile compounding standards.

Discard it immediately. Cloudiness indicates peptide aggregation or microbial contamination. Both render the compound unusable. Colour change (yellowing, darkening) suggests oxidative degradation. These are not reversible. Attempting to use degraded peptide introduces an uncontrolled variable into your research and may produce misleading results. Prevent this by: storing at 2–8°C consistently, protecting from light, using pharmaceutical-grade BAC water, and following aseptic technique during every draw.

Use the entire vial within 24 hours or discard it. Sterile water lacks the benzyl alcohol preservative that prevents bacterial growth, meaning every subsequent draw after the first needle puncture introduces contamination risk that compounds exponentially. If you've already drawn multiple doses over several days, assume the peptide has degraded. Bacterial enzymes released into the solution cleave peptide bonds even if visible contamination hasn't appeared. For researchers mid-protocol with compounds like MK 677 or Hexarelin, reconstitute a fresh vial with proper BAC water rather than risk injecting a degraded or contaminated solution.

Discard it if the ambient temperature exceeded 25°C for more than eight hours. Peptides like Sermorelin, Ipamorelin, and CJC 1295 lose 40–60% potency after prolonged exposure to room temperature due to accelerated hydrogen bond disruption and oxidation. If the vial was at 18–22°C for under six hours, refrigerate it immediately and use it within seven days. But expect reduced bioactivity. There's no reliable at-home test for peptide potency, so the conservative approach is to assume significant degradation occurred and reconstitute a replacement vial.

Maintain 2–8°C temperature throughout transit using a purpose-built medication cooler with temperature logging capability. TSA regulations permit medically necessary liquids in carry-on luggage when properly labelled. Use gel-based cold packs (not loose ice) to maintain stable refrigeration without risk of freezing. Test your cooler before travel: place a calibrated thermometer inside and monitor temperature over 24 hours to confirm it stays between 2–8°C. Temperature excursions above 25°C for more than four hours reduce peptide potency by 20–30%. Once that degradation occurs, it cannot be reversed. If you cannot maintain cold chain integrity during travel, reconstitute a fresh vial at your destination rather than transporting a compromised compound.

Use the reconstituted peptide within 24 hours or discard it. Sterile water contains no benzyl alcohol preservative, so every needle puncture introduces contamination risk. By 48 hours, bacterial growth is likely even if no visible cloudiness appears. Do not attempt to extend storage beyond 24 hours. The contamination risk outweighs the cost of the lost peptide. For future reconstitutions, label your vials clearly: 'BWFI' for bacteriostatic water and 'SWFI' for sterile water to prevent mix-ups.

Use a medical-grade cooler that maintains 2–8°C for the entire transport duration. Insulin travel cases with gel ice packs work well for trips under 12 hours. Peptides like Tirzepatide and Retatrutide tolerate short-term temperature fluctuations better than growth hormone peptides, but any excursion above 10°C begins the degradation clock. For air travel, TSA permits peptides in carry-on luggage with a prescription or research documentation. Never check reconstituted peptides in cargo holds where temperatures can reach 30–40°C. If you cannot maintain cold chain integrity during transport, it's safer to reconstitute a fresh vial at your destination rather than risk using a temperature-compromised solution.